Mediterranean Journal of Rheumatology最新文献_第3页

Fractional Carbon Dioxide Laser for Treatment of Microstomia and Rhytids in Systemic Sclerosis Patients. 点阵二氧化碳激光治疗系统性硬化症患者的小口畸形和韵律畸形。

Mediterranean Journal of Rheumatology Pub Date : 2024-05-21 eCollection Date: 2024-09-01 DOI: 10.31138/mjr.101223.fcd

Elias Salimi, Shirin Assar, Aram Salimi, Dena Mohamadzadeh

{"title":"Fractional Carbon Dioxide Laser for Treatment of Microstomia and Rhytids in Systemic Sclerosis Patients.","authors":"Elias Salimi, Shirin Assar, Aram Salimi, Dena Mohamadzadeh","doi":"10.31138/mjr.101223.fcd","DOIUrl":"10.31138/mjr.101223.fcd","url":null,"abstract":"Background: Systemic sclerosis (SSc) is an autoimmune disorder characterised by skin fibrosis leading to skin tightening and disfigurement. However, there is no definite treatment for SSc and its skin complications. Fractional carbon dioxide laser has been widely used for different cutaneous pathologies. This study aims to evaluate the benefits of CO2 laser resurfacing on microstomia and peri-oral rhytids in systemic sclerosis patients.Method and patients: 33 systemic sclerosis patients were enrolled. Four sessions of CO2 laser treatment were performed at an interval of four weeks. Patients were evaluated monthly. The interincisal distance (IID) measurement was used to evaluate maximal mouth opening capacity, and the mouth handicap in systemic sclerosis (MHISS) scale was used to assess the improvement after treatment.Results: All of the participants were female with a mean age of 47.46 and a standard deviation of 7.11. The mean disease duration was 12.35. The mean total core of the MHISS scale was 25.24, and the mean IID was 48.11 millimetres before the treatment with CO2 laser. The MHISS score decreased, and patient satisfaction increased after treatment. However, observed differences in the results of IID were not statistically significant.Conclusion: In conclusion, it seems that the fractional carbon dioxide laser is effective in the improvement of perioral rhytids, patient satisfaction based on the MHISS score, and mouth disability in SSc patients.","PeriodicalId":32816,"journal":{"name":"Mediterranean Journal of Rheumatology","volume":"35 3","pages":"459-463"},"PeriodicalIF":0.0,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11500117/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Sjögren's Syndrome Masquerading as Testicular Vasculitis. 伪装成睾丸血管炎的斯约格伦综合征

Mediterranean Journal of Rheumatology Pub Date : 2024-05-21 eCollection Date: 2024-09-01 DOI: 10.31138/mjr.250323.ssm

Rajaie Namas, Hamdan Alawadhi, Priti Joshi, Esat Memisoglu

引用次数: 0

Cutaneous Ulcers and Response to Treatment in a Child with Anti-MDA5 Dermatomyositis. 一名抗MDA5皮肌炎患儿的皮肤溃疡和治疗反应

Mediterranean Journal of Rheumatology Pub Date : 2024-05-21 eCollection Date: 2024-06-01 DOI: 10.31138/mjr.191123.cua

Mamadapur Mahabaleshwar, Ramaswamy Subramanian

引用次数: 0

Spectrum of Central Nervous System Involvement in Childhood-Onset Sjögren's Syndrome: A Case-Based Review. 儿童期发病的斯约格伦综合征的中枢神经系统受累谱：基于病例的综述。

Mediterranean Journal of Rheumatology Pub Date : 2024-05-21 eCollection Date: 2024-06-01 DOI: 10.31138/mjr.241123.soc

Furkan Can Yilmaz, Hakan Kisaoglu, Ozge Baba, Mukaddes Kalyoncu

{"title":"Spectrum of Central Nervous System Involvement in Childhood-Onset Sjögren's Syndrome: A Case-Based Review.","authors":"Furkan Can Yilmaz, Hakan Kisaoglu, Ozge Baba, Mukaddes Kalyoncu","doi":"10.31138/mjr.241123.soc","DOIUrl":"https://doi.org/10.31138/mjr.241123.soc","url":null,"abstract":"Sjögren's syndrome (SS) is less frequently diagnosed in childhood than in adults, and central nervous system (CNS) disease is among the rarest systemic involvements. Thus, the clinical spectrum of CNS diseases and their management strategies have not been fully defined. In this article, we present the case of a 16-year-old girl who was referred for severe headache and diagnosed with SS with CNS involvement. Several immunosuppressive treatments failed to improve her neurological symptoms until the rituximab treatment. When we systematically reviewed the literature on cases of CNS involvement in childhood-onset SS, we found that CNS involvement was the presenting feature at the diagnosis of SS in the majority of published cases. While headache and fever were the most frequent complaints at presentation, most of the children displayed features of neuromyelitis optica spectrum disorder. CNS disease showed a variable response to immunosuppressives, and residual neurological deficits were not rare. Additionally, a significant number of cases required treatment with rituximab due to the treatment failures or subsequent flares. Sjögren's syndrome should be considered in children presenting with predominant neurological symptoms, and careful evaluation of glandular features might help in the prompt diagnosis of childhood-onset SS in children with CNS disease.","PeriodicalId":32816,"journal":{"name":"Mediterranean Journal of Rheumatology","volume":"35 2","pages":"298-304"},"PeriodicalIF":0.0,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350415/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

COVID-19-Induced Rheumatoid Arthritis: Case Series and Systematic Review of the Literature. COVID-19诱发的类风湿性关节炎：病例系列和文献系统性综述。

Mediterranean Journal of Rheumatology Pub Date : 2024-05-21 eCollection Date: 2024-06-01 DOI: 10.31138/mjr.171223.cir

Selma Bouden, Hiba Ben Ayed, Leila Rouached, Aicha Ben Tekaya, Ines Mahmoud, Raoudha Tekaya, Olfa Saidane, Leila Abdelmoula

引用次数: 0

Adult-Onset Still's Disease with Distinctive Skin Signs and Elevated LDH. 伴有明显皮肤症状和 LDH 升高的成年型 Still's 病。

Mediterranean Journal of Rheumatology Pub Date : 2024-05-21 eCollection Date: 2024-06-01 DOI: 10.31138/mjr.200224.aod

Eleni Klimi, Evaggelia Kataxaki

引用次数: 0

Vegan Glucosamine versus Crustacean Glucosamine in Osteoarthritis: Choosing the Correct One During Clinical Practice. 骨关节炎中的素食葡萄糖胺与甲壳动物葡萄糖胺：在临床实践中正确选择。

Mediterranean Journal of Rheumatology Pub Date : 2024-04-23 eCollection Date: 2024-06-01 DOI: 10.31138/mjr.201223.vgv

Hitesh Verma

引用次数: 0

2023 EULAR Recommendations for the Treatment of PsA: Advances and Pending Issues. 2023 EULAR 关于治疗 PsA 的建议：进展与悬而未决的问题。

Mediterranean Journal of Rheumatology Pub Date : 2024-04-15 eCollection Date: 2024-06-01 DOI: 10.31138/mjr.050424.ert

Philipp Sewerin, Xenofon Baraliakos

引用次数: 0

New-Onset, Treatment-Resistant Inflammatory Bowel Disease after Administration of Secukinumab for Plaque Psoriasis: A Case Report and Review of the Existing Literature. 使用塞库单抗治疗斑块型银屑病后新发的难治性炎症性肠病：病例报告和现有文献综述。

Mediterranean Journal of Rheumatology Pub Date : 2024-03-31 eCollection Date: 2024-03-01 DOI: 10.31138/mjr.030124.ntt

Michail Krikelis, Evgenia Papathanasiou, George Leonidakis, Pavlos Pardalis, Spyridon Michopoulos, Evanthia Zampeli

{"title":"New-Onset, Treatment-Resistant Inflammatory Bowel Disease after Administration of Secukinumab for Plaque Psoriasis: A Case Report and Review of the Existing Literature.","authors":"Michail Krikelis, Evgenia Papathanasiou, George Leonidakis, Pavlos Pardalis, Spyridon Michopoulos, Evanthia Zampeli","doi":"10.31138/mjr.030124.ntt","DOIUrl":"10.31138/mjr.030124.ntt","url":null,"abstract":"Introduction: Aberrant activation of the IL-23/IL-17 axis leads to inflammatory phenotypes with overlapping clinical characteristics. Inhibition of IL-17 has mostly an anti-inflammatory effect, but sporadic cases of new-onset IBD have been reported.Case description: We present the case of a 65-year-old male patient with new-onset Crohn's-like disease after treatment with secukinumab for skin psoriasis. Discontinuation of the IL-17 inhibitor and high-dose corticosteroid treatment were efficient initially, but a relapse was noted during corticosteroid tapering. Administration of certolizumab pegol did partially relieve the patient, but disease remission was only achieved with subcutaneous risankizumab therapy.Discussion: Clinical trials and real-world data indicate sporadic cases of new-onset IBD in patients receiving IL-17 inhibitors. Interestingly, our case is a \"treatment-resistant\" one since treatment with a biologic disease-modifying drug (bDMARD) usually leads to disease remission. As such, it is crucial to investigate the special characteristics of this clinical entity.","PeriodicalId":32816,"journal":{"name":"Mediterranean Journal of Rheumatology","volume":"35 1","pages":"150-155"},"PeriodicalIF":0.0,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082766/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140912940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

EULAR 2023 Recommendations for the Management of Systemic Lupus Erythematosus: One Step Forward. EULAR 2023 系统性红斑狼疮管理建议：向前一步。

Mediterranean Journal of Rheumatology Pub Date : 2024-03-31 eCollection Date: 2024-03-01 DOI: 10.31138/mjr.130124.erm

Georgia-Savina Moysidou, Antonis Fanouriakis

引用次数: 0